Abstract
Background
This study examined the association of cholelithiasis post-cholecystectomy with subsequent cancers and evaluated the risk of cancer in patients with both cholelithiasis and cholecystectomy.
Methods
The Taiwanese National Health Insurance Research Database was used to identify 15545 newly diagnosed cholelithiasis patients from 2000 to 2010, and 62180 frequency-matched non-cholelithiasis patients. A total of 5850 (37.6 %) with cholelithiasis patients received a cholecystectomy. The risk of developing cancer after cholecystectomy was measured using the Cox proportional-hazards model.
Results
The incidence of developing cancer in the cholelithiasis cohort was 1.52-fold higher than that in the comparison cohort (p < 0.001). Compared with patients aged 20–34 years, patients in older age groups had a higher risk of developing cancer. The hazard ratio (HR) for developing gallbladder, extrahepatic bile duct, pancreatic, liver, stomach, and colorectal cancer was 59.3, 10.7, 3.12, 1.90, 1.71, and 1.36-fold higher for patients with cholelithiasis, respectively. After a cholecystectomy, the HR for developing stomach and colorectal cancer was 1.81-fold and 1.56-fold, respectively. The incidence rate ratio was higher for the first 5 years and over 5 years (5.05 and 4.46, respectively) (95 % confidence interval 4.73–5.39 and 4.11–4.84, respectively) in proximal colon and stomach cancer patients with cholecystectomies.
Conclusions
Cholelithiasis patients have a higher risk of gastrointestinal cancer, particularly of gallbladder and extrahepatic bile duct cancer. Post-cholecystectomy patients have a risk of colorectal and stomach cancer within the first 5 years and persisting after 5 years, respectively. This paper proposes strategies for preventing gastrointestinal cancer.
Similar content being viewed by others
References
Agrawal S, Jonnalagadda S. Gallstones, from gallbladder to gut: management options for diverse complications. Postgrad Med. 2000;108:143–53.
Huang J, Chang CH, Wang JL, et al. Nationwide epidemiological study of severe gallstone disease in Taiwan. BMC Gastroenterol. 2009;9:63.
Lowenfels AB, Lindstršm CG, Conway MJ, et al. Gallstones and risk of gallbladder cancer. J Natl Cancer Inst. 1985;75:77–80.
Chow WH, Johansen C, Gridley G, et al. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer. 1999;79:640–4.
Almond HR, Vlahcevic ZR, Bell CC, et al. Bile acid pools, kinetics and biliary lipid composition before and after cholecystectomy. N Engl J Med. 1973;289:1213–6.
Ekbom A, Yuen J, Adami HO, et al. Cholecystectomy and colorectal cancer. Gastroenterology. 1993;105:142–7.
Gustavsson S, Adami HO, Meirik O, et al. Cholecystectomy as a risk factor for gastric cancer. A cohort study. Dig Dis Sci. 1984;29:116–20.
Giovannucci E, Colditz GA, Stampfer MJ. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology. 1993;105:130–41.
Reid FD, Mercer PM, Harrison M, et al. Cholecystectomy as a risk factor for colorectal cancer: a meta-analysis. Scand J Gastroenterol. 1996;31:160–9.
Ge Z, Zhao C, Wang Y, et al. Cholecystectomy and the risk of esophageal and gastric cancer. Saudi Med J. 2012;33:1073–9.
Tavani A, Rosato V, Di Palma F, et al. History of cholelithiasis and cancer risk in a network of case–control studies. Ann Oncol. 2012;23:2173–8.
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.
Urbach DR, Stukel TA. Rate of elective cholecystectomy and the incidence of severe gallstone disease. CMAJ. 2005;172:1015–9.
Hung SC, Liao KF, Lai SW, et al. Risk factors associated with symptomatic cholelithiasis in Taiwan: a population-based study. BMC Gastroenterol. 2011;11:111.
Yu YH, Liao CC, Hsu WH, et al. Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study. J Thorac Oncol. 2011;6:32–7.
Liang JA, Sun LM, Yeh JJ, et al. Malignancies associated with systemic lupus erythematosus in Taiwan: a nationwide population-based cohort study. Rheumatol Int. 2012;32:773–8.
Cheng CL, Kao YH, Lin SJ, et al. Lai Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20:236–42.
Kang JH, Chen YH, Lin HC. Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study. Ann Rheum Dis. 2010;69:1165–8.
Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012;6:172–87.
Lowenfels AB. Gallstones and the risk of cancer. Gut. 1980;21:1090–2.
Johansen C, Chow WH, Jorgensen T, et al. Risk of colorectal cancer and other cancers in patients with gallstones. Gut. 1996;39:439–43.
Ho KJ, Lin XZ, Yu SC, Chen JS, Wu CZ. Cholelithiasis in Taiwan. Gallstone characteristics, surgical incidence, bile lipid composition, and role of beta-glucuronidase. Dig Dis Sci. 1995;40:1963–73.
Hung SC, Liao KF, Lai SW, Li CI, Chen WC. Risk factors associated with symptomatic cholelithiasis in Taiwan: a population-based study. BMC Gastroenterol. 2011;11:111.
Ho KJ, Lin XZ, Yu SC, et al. Cholelithiasis in Taiwan. Gallstone characteristics, surgical incidence, bile lipid composition, and role of beta-glucuronidase. Dig Dis Sci. 1995;40:1963–73.
Yoo EH, Oh HJ, Lee SY. Gallstone analysis using Fourier transform infrared spectroscopy (FT-IR). Clin Chem Lab Med. 2008;46:376–81.
Chen CH, Huang MH, Yang JC, et al. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey. J Gastroenterol Hepatol. 2006;21:1737–43.
Sheen IS, Liaw YF. The prevalence and incidence of cholecystolithiasis in patients with chronic liver diseases: a prospective study. Hepatology. 1989;9:538–40.
Lagergren J, Ye W, Ekbom A. Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology. 2001;121:542–7.
Schernhammer ES, Leitzmann MF, Michaud DS, et al. Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas. Br J Cancer. 2003;88:79–83.
Shao T, Yang YX. Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterol. 2005;100:1813–20.
Goldacre MJ, Abisgold JD, Seagroatt V, et al. Cancer after cholecystectomy: record-linkage cohort study. Br J Cancer. 2005;92:1307–9.
Altieri A, Pelucchi C, Talamini R, et al. Cholecystectomy and the risk of colorectal cancer in Italy. Br J Cancer. 2004;90:1753–5.
Fall K, Ye W, Nyren O. Risk for gastric cancer after cholecystectomy. Am J Gastroenterol. 2007;102:1180–4.
Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008;454:436–44.
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–99.
Acknowledgments
This work was supported by grants from China Medical University Hospital (DMR-102-014 and DMR-102-023); the Taiwan Department of Health, Clinical Trial and Research Center for Excellence (DOH102-TD-B-111-004); the Taiwan Department of Health, Cancer Research Center for Excellence (DOH102-TD-C-111-005); and the International Research-Intensive Centers of Excellence, Taiwan (NSC101-2911-I-002-303).
Conflict of interest
All authors state that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, YK., Yeh, JH., Lin, CL. et al. Cancer risk in patients with cholelithiasis and after cholecystectomy: a nationwide cohort study. J Gastroenterol 49, 923–931 (2014). https://doi.org/10.1007/s00535-013-0846-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-013-0846-6